Home › Melanoma › Tennessee › Knoxville
Melanoma clinical trials in Knoxville, TN
5 studies for Melanoma are looking for participants at sites in and around Knoxville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RecruitingPhase 3
- University of Tennessee Medical Center, Knoxville
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
RecruitingPhase 2
- East Tennessee Childrens Hospital, Knoxville
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- East Tennessee Childrens Hospital, Knoxville
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecruitingPhase 2/3
- University of Tennessee Medical Center, Knoxville
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
RecruitingPhase 3
- University of Tennessee Medical Center, Knoxville
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN33 studies
- Pittsburgh, PA31 studies
- Boston, MA26 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- St. Louis, MO21 studies
- Durham, NC21 studies
- Salt Lake City, UT21 studies
- Columbus, OH21 studies
Other studies in Knoxville
- Non-Small Cell Lung Cancer14 studies
- Obesity10 studies
- Lung Cancer10 studies
- Breast Cancer9 studies
- Cancer (all types)8 studies
- Overweight7 studies
- Heart Failure7 studies
- Metastatic Cancer7 studies
- Cardiovascular Disease6 studies
- Type 2 Diabetes5 studies
- High Blood Pressure5 studies
- COPD5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.